Even if the findings of this study have to be seen in light of some limitations related to the size of the population included in the study and the use of a previous classification system for CNS tumours (2007 CNS WHO), the use of either proteasome or 5-LOX inhibitors could be thus explored in order to sensitize PBT cells to ICIs. This evidence concerns the gene ALOX5 and central nervous system neoplasm.